Image Analysis Group

Link: https://www.ia-grp.com/views/biotech-and-tech-2021/

Opinion piece on what to expect in 2021 - huge IT challenges or the Right Solutions coming in the right time? Will this be the year to reward those who are breaking the mould and pushing adaptation of innovation across the therapeutic areas.

This piece is focused on a few technology solutions, which can make a real difference in biotech / pharma drug development and help the sector can prevail over covid:

, technologies that support while
enabling data sharing, , , and for acceleration and decision making.

Data Privacy and Data Exchange
Vaccine Passports
Drug Development for Diseases other the Covid
AI: from Computer-Aided Assessments to Radiomics
From Telehealth to Objective Metrics of Drug Performance.

with IAG, IMAGE ANALYSIS GROUP

https://www.linkedin.com/pulse/biotech-tech-2021-dr-olga-kubassova

Biotech and Tech: 2021+ We are out of the 2020, and into 2021, reminiscing of the first lockdowns and re-analysing the biotech sector rise. On our minds, probably daily – is the vaccine challenge, especially as both Pfizer and AstraZeneca are warning about the vaccine shortages.